These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31877015)

  • 1. Discovery of a Small Molecule Probe of Rpn-6, an Essential Subunit of the 26S Proteasome.
    Tian W; Trader DJ
    ACS Chem Biol; 2020 Feb; 15(2):554-561. PubMed ID: 31877015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to Evaluate the Impact of a Small-Molecule Binder to a Noncatalytic Site of the Proteasome.
    Tian W; Maresh ME; Trader DJ
    Chembiochem; 2021 Jun; 22(11):1961-1965. PubMed ID: 33617657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancers.
    Loy CA; Muli CS; Ali EMH; Xie D; Ahmed MH; Beth Post C; Trader DJ
    Bioorg Med Chem Lett; 2023 Oct; 95():129485. PubMed ID: 37714498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-depth Analysis of the Lid Subunits Assembly Mechanism in Mammals.
    Bai M; Zhao X; Sahara K; Ohte Y; Hirano Y; Kaneko T; Yashiroda H; Murata S
    Biomolecules; 2019 May; 9(6):. PubMed ID: 31159305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors.
    Troiano V; Scarbaci K; Ettari R; Micale N; Cerchia C; Pinto A; Schirmeister T; Novellino E; Grasso S; Lavecchia A; Zappalà M
    Eur J Med Chem; 2014 Aug; 83():1-14. PubMed ID: 24946214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Driven Developments of 26S Proteasome Inhibitors.
    Śledź P; Baumeister W
    Annu Rev Pharmacol Toxicol; 2016; 56():191-209. PubMed ID: 26738474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subunit-subunit interactions in the human 26S proteasome.
    Chen C; Huang C; Chen S; Liang J; Lin W; Ke G; Zhang H; Wang B; Huang J; Han Z; Ma L; Huo K; Yang X; Yang P; He F; Tao T
    Proteomics; 2008 Feb; 8(3):508-20. PubMed ID: 18186020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-range allosteric regulation of the human 26S proteasome by 20S proteasome-targeting cancer drugs.
    Haselbach D; Schrader J; Lambrecht F; Henneberg F; Chari A; Stark H
    Nat Commun; 2017 May; 8():15578. PubMed ID: 28541292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Telomerase Reverse Transcriptase (hTERT) Positively Regulates 26S Proteasome Activity.
    Im E; Yoon JB; Lee HW; Chung KC
    J Cell Physiol; 2017 Aug; 232(8):2083-2093. PubMed ID: 27648923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chaperone-driven proteasome assembly.
    Rosenzweig R; Glickman MH
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):807-12. PubMed ID: 18793141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiostrepton interacts covalently with Rpt subunits of the 19S proteasome and proteasome substrates.
    Sandu C; Chandramouli N; Glickman JF; Molina H; Kuo CL; Kukushkin N; Goldberg AL; Steller H
    J Cell Mol Med; 2015 Sep; 19(9):2181-92. PubMed ID: 26033448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the human 26S proteasome: subunit radial displacements open the gate into the proteolytic core.
    da Fonseca PC; Morris EP
    J Biol Chem; 2008 Aug; 283(34):23305-14. PubMed ID: 18534977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase UBLCP1 controls proteasome assembly.
    Sun S; Liu S; Zhang Z; Zeng W; Sun C; Tao T; Lin X; Feng XH
    Open Biol; 2017 May; 7(5):. PubMed ID: 28539385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic addiction to high 26S proteasome level.
    Tsvetkov P; Adler J; Myers N; Biran A; Reuven N; Shaul Y
    Cell Death Dis; 2018 Jul; 9(7):773. PubMed ID: 29991718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma.
    Zhou Y; Liu X; Xue J; Liu L; Liang T; Li W; Yang X; Hou X; Fang H
    J Med Chem; 2020 May; 63(9):4701-4715. PubMed ID: 32267687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological methods to quantify and characterize proteasome complexes: development and application.
    Majetschak M; Sorell LT
    J Immunol Methods; 2008 May; 334(1-2):91-103. PubMed ID: 18343400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-translationally modified S12, absent in transformed breast epithelial cells, is not associated with the 26S proteasome and is induced by proteasome inhibitor.
    Thompson HG; Harris JW; Brody JP
    Int J Cancer; 2004 Sep; 111(3):338-47. PubMed ID: 15221960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting protein-protein interactions in proteasome assembly: Implication to its self-assembly.
    Pilla SP; R B; Bahadur RP
    J Mol Recognit; 2019 Sep; 32(9):e2784. PubMed ID: 31044461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.
    Raynes R; Pomatto LC; Davies KJ
    Mol Aspects Med; 2016 Aug; 50():41-55. PubMed ID: 27155164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaperone-assisted assembly of the proteasome core particle.
    Matias AC; Ramos PC; Dohmen RJ
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):29-33. PubMed ID: 20074030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.